Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001321543-05-000067
Filing Date
2005-08-02
Accepted
2005-08-02 14:40:31
Documents
1
Period of Report
2005-08-01

Document Format Files

Seq Description Document Type Size
1 gfs01641_ex.html 4  
1 gfs01641_ex.xml 4 7125
  Complete submission text file 0001321543-05-000067.txt   9048
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Issuer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address ALPHA BIOMEDICALS INC 3 BETHESDA METRO CENTER BETHESDA MD 20814 3019611992
GOLDSTEIN ALLAN L (Reporting) CIK: 0000905390 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15070 | Film No.: 05991475